Katherine K Elder, PHD | |
31502 Heron Cir, Lewes, DE 19958-3601 | |
(609) 517-1529 | |
(302) 827-4856 |
Full Name | Katherine K Elder |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 31502 Heron Cir, Lewes, Delaware |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316244700 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | PC0000534 (Delaware) | Secondary |
103TC0700X | Psychologist - Clinical | B1-0001075 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Katherine K Elder, PHD 31502 Heron Cir, Lewes, DE 19958-3601 Ph: (609) 517-1529 | Katherine K Elder, PHD 31502 Heron Cir, Lewes, DE 19958-3601 Ph: (609) 517-1529 |
News Archive
According to a report by the Health Protection Agency (HPA) in Britain, migrants are far more likely to have HIV, TB or malaria than the rest of the population.
E-cigarettes may be on the rise, with 21% of UK consumers aged between 18 and 24 occasionally or regularly vaping in 2018, but it is risky for NHS hospitals to start showing support for the practice as the long-term effects of vaping are still unknown, says GlobalData, a leading data and analytics company.
Summer means more hours of daylight and for many, it contributes to trouble falling asleep. More than 40 million Americans suffer from chronic sleep disorders, resulting in $18 billion in cost to employers due to sleep loss issues.
Though the cause of Alzheimer's disease still is unknown, recent studies have implicated three proteins strongly in its onset. New research from the University of Alabama at Birmingham, the Gladstone Institutes and the Baylor College of Medicine indicates that interactions between those three proteins might lead to brain dysfunction and AD in a mouse model of the disease.
Roche (Basel) and Mirus Bio Corporation (Madison, WI, USA) announced today that they have entered into a definitive agreement under which Roche will acquire Mirus Bio Corporation, a privately-owned US company based in Madison, Wisconsin, that focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform.
› Verified 8 days ago